Benefit

Home ▶ Benefit
ATS Foundation Research Program Benefit

The ATS Foundation Research Program Benefit, held during the ATS International Conference, brings together the best and brightest across the respiratory spectrum to support research. The annual Benefit is an ideal opportunity for individuals, medical institutions, and corporate sponsors to contribute:

For more information on Benefit corporate or institutional packages, please contact Michelle Turenne at mturenne@thoracic.org or 212-315-6448.

For more information on Benefit academic medical institution, nonprofit organization, or individual ticket packages, please contact Lydia Neumann at lneumann@thoracic.org or 212-315-8622.


 

Stay tuned for updates about the Eighth Annual ATS Foundation Research Program Benefit in San Francisco in 2016.

We hope to see you there!

  • Enjoy wine, beer, delicious food, music, and dancing
  • Socialize with friends and colleagues
  • Honor the ATS Foundation Breathing for Life Award recipient and the Research Program awardees
  • Support the ATS Foundation Research Program—and launch careers dedicated to scientific discovery and better patient care

Frequently Asked Questions

  • When, where and what to wear to the Benefit

WATCH: Dr. Marvin Schwarz, the 2015 Breathing for Life Awardee


Photo albums:

Check out photos from the 2015 Benefit, which honored Marvin Schwarz, MD, with the Breathing for Life Award

Check out photos from the 2014 Benefit, which honored William Busse, MD, with the Breathing for Life Award

Plus, read more about the 2015 Benefit

 

The Breathing for Life Award is the highest honor conferred by the ATS Foundation for exemplary philanthropic and scientific contributions. Previous Breathing for Life Award recipients include:

  • 2015 - Marvin Schwarz, MD
  • 2014 - William Busse, MD
  • 2013 - Gerard Turino, MD
  • 2012 - Talmadge King, Jr., MD
  • 2011 - Louis Libby, MD
  • 2010 - Senator Mike Crapo (R-Idaho)
  • 2009 - ATS Public Advisory Round Table (PAR)

The ATS Foundation thanks the many individuals and 27 medical institutions that supported the Seventh Annual Research Program Benefit.

The ATS Foundation thanks Genentech for support at the Sapphire Level for the Seventh Annual Research Program Benefit; Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech-Novartis at the Platinum Level; AstraZeneca LP and the University of Colorado Health at the Gold Level; Freeman, MEDA Pharmaceuticals, Inc., and Teva Respiratory at the Silver Level.


Donate